Axa S.A. Has $226.22 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Axa S.A. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 447,189 shares of the healthcare conglomerate's stock after selling 67,301 shares during the period. UnitedHealth Group makes up 0.7% of Axa S.A.'s investment portfolio, making the stock its 23rd biggest holding. Axa S.A.'s holdings in UnitedHealth Group were worth $226,215,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Principal Financial Group Inc. grew its holdings in UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after purchasing an additional 180,479 shares during the last quarter. Franklin Resources Inc. raised its holdings in UnitedHealth Group by 2.5% in the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock worth $4,884,019,000 after acquiring an additional 193,800 shares during the period. Versant Capital Management Inc grew its position in shares of UnitedHealth Group by 36.1% in the fourth quarter. Versant Capital Management Inc now owns 1,376 shares of the healthcare conglomerate's stock valued at $696,000 after purchasing an additional 365 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of UnitedHealth Group by 2.5% during the 4th quarter. GAMMA Investing LLC now owns 14,749 shares of the healthcare conglomerate's stock worth $7,461,000 after purchasing an additional 356 shares during the last quarter. Finally, Pensionfund Sabic increased its position in UnitedHealth Group by 48.4% in the 4th quarter. Pensionfund Sabic now owns 9,350 shares of the healthcare conglomerate's stock worth $4,730,000 after buying an additional 3,050 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $398.72 on Friday. The business's fifty day moving average is $495.85 and its two-hundred day moving average is $528.74. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $393.11 and a 52 week high of $630.73. The firm has a market cap of $362.92 billion, a P/E ratio of 25.72, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the firm posted $6.91 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 2.11%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

Analysts Set New Price Targets

UNH has been the topic of several research analyst reports. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Oppenheimer cut their price objective on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a research report on Monday, April 21st. JPMorgan Chase & Co. cut their price target on UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Argus lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Finally, Truist Financial decreased their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research note on Monday, April 21st. Three equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.